Sirio Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 18.11% vs 10.43% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 11.46% vs -3.76% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,249.60",
          "val2": "1,058.00",
          "chgp": "18.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "119.60",
          "val2": "170.30",
          "chgp": "-29.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "26.70",
          "val2": "27.40",
          "chgp": "-2.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.70",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "85.60",
          "val2": "76.80",
          "chgp": "11.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "95.70%",
          "val2": "90.60%",
          "chgp": "0.51%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.47% vs 43.30% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.35% vs 13.19% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,195.60",
          "val2": "3,571.50",
          "chgp": "17.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "689.00",
          "val2": "581.00",
          "chgp": "18.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "97.30",
          "val2": "79.60",
          "chgp": "22.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-21.90",
          "val2": "-57.70",
          "chgp": "62.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "282.00",
          "val2": "240.30",
          "chgp": "17.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "95.50%",
          "val2": "89.00%",
          "chgp": "0.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

1,249.60

1,058.00

18.11%

Operating Profit (PBDIT) excl Other Income

119.60

170.30

-29.77%

Interest

26.70

27.40

-2.55%

Exceptional Items

0.00

1.70

-100.00%

Consolidate Net Profit

85.60

76.80

11.46%

Operating Profit Margin (Excl OI)

95.70%

90.60%

0.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 18.11% vs 10.43% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 11.46% vs -3.76% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

4,195.60

3,571.50

17.47%

Operating Profit (PBDIT) excl Other Income

689.00

581.00

18.59%

Interest

97.30

79.60

22.24%

Exceptional Items

-21.90

-57.70

62.05%

Consolidate Net Profit

282.00

240.30

17.35%

Operating Profit Margin (Excl OI)

95.50%

89.00%

0.65%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 17.47% vs 43.30% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 17.35% vs 13.19% in Dec 2023

All Annual Results